Capricor Therapeutics Total Assets 2006-2019 | CAPR

Capricor Therapeutics total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Capricor Therapeutics Annual Total Assets
(Millions of US $)
2018 $9
2017 $16
2016 $19
2015 $16
2014 $14
2013 $6
2012 $5
2011 $1
2010 $4
2009 $4
2008 $6
2007 $17
2006 $0
2005 $0
Capricor Therapeutics Quarterly Total Assets
(Millions of US $)
Q3 2019 $8
Q2 2019 $7
Q1 2019 $9
Q4 2018 $9
Q3 2018 $12
Q2 2018 $14
Q1 2018 $15
Q4 2017 $16
Q3 2017 $16
Q2 2017 $14
Q1 2017 $14
Q4 2016 $19
Q3 2016 $24
Q2 2016 $14
Q1 2016 $17
Q4 2015 $16
Q3 2015 $20
Q2 2015 $24
Q1 2015 $27
Q4 2014 $14
Q3 2014 $16
Q2 2014 $18
Q1 2014 $16
Q4 2013 $6
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $5
Q3 2012 $0
Q2 2012 $1
Q1 2012 $1
Q4 2011 $1
Q3 2011 $3
Q2 2011 $4
Q1 2011 $2
Q4 2010 $4
Q3 2010 $5
Q2 2010 $6
Q1 2010 $2
Q4 2009 $4
Q3 2009 $5
Q2 2009 $2
Q1 2009 $4
Q4 2008 $6
Q3 2008 $8
Q2 2008 $11
Q1 2008 $14
Q4 2007 $17
Q3 2007 $19
Q2 2007 $0
Q1 2007 $0
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $0
Q3 2005 $0
Q2 2005 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.007B $0.002B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.743B 27.50
Medtronic (MDT) Ireland $150.390B 20.78
Stryker (SYK) United States $76.022B 25.56
Boston Scientific (BSX) United States $60.297B 28.46
Baxter (BAX) United States $42.111B 25.54
Essilor Luxottica (ESLOY) France $33.472B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.363B 19.05
Terumo (TRUMY) Japan $27.248B 34.00
Coloplast (CLPBY) Denmark $25.801B 39.82
Lonza Group Ag (LZAGY) Switzerland $25.334B 0.00
ResMed (RMD) United States $21.594B 39.84
Smith & Nephew SNATS (SNN) United Kingdom $19.340B 0.00
Sunny Optical Technology (SNPTF) China $18.646B 0.00
Insulet (PODD) United States $11.389B 541.85
Bio-Rad Laboratories (BIO) United States $11.046B 53.02
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.116B 20.98
Perrigo (PRGO) Ireland $7.052B 13.15
Canopy Growth (CGC) Canada $6.483B 0.00
Haemonetics (HAE) United States $6.072B 41.03
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.839B 30.23
ICU Medical (ICUI) United States $3.808B 24.83
Neogen (NEOG) United States $3.557B 59.53
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.227B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.198B 0.00
Quidel (QDEL) United States $2.876B 27.29
Aurora Cannabis (ACB) Canada $2.658B 0.00
National Vision Holdings (EYE) United States $2.391B 53.96
Agios Pharmaceuticals (AGIO) United States $2.360B 0.00
Cardiovascular Systems (CSII) United States $1.544B 0.00
InMode (INMD) Israel $1.393B 0.00
Aphria (APHA) $1.177B 0.00
AtriCure (ATRC) United States $1.174B 0.00
VAREX IMAGING (VREX) United States $1.159B 23.21
Phibro Animal Health (PAHC) United States $0.973B 18.23
NanoString Technologies (NSTG) United States $0.941B 0.00
Lantheus Holdings (LNTH) United States $0.805B 20.11
TG Therapeutics (TGTX) United States $0.765B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 29.02
LeMaitre Vascular (LMAT) United States $0.717B 40.31
Quanterix (QTRX) United States $0.696B 0.00
Omeros (OMER) United States $0.662B 0.00
PetIQ (PETQ) United States $0.660B 16.09
Cerus (CERS) United States $0.573B 0.00
Surmodics (SRDX) United States $0.551B 57.32
HEXO (HEXO) $0.530B 0.00
OraSure Technologies (OSUR) United States $0.478B 28.67
MacroGenics (MGNX) United States $0.453B 0.00
Owens & Minor (OMI) United States $0.444B 16.44
Organigram Holdings (OGI) Canada $0.409B 0.00
Meridian Bioscience (VIVO) United States $0.389B 13.37
Utah Medical Products (UTMD) United States $0.387B 28.03
BioLife Solutions (BLFS) United States $0.329B 133.92
Zynex (ZYXI) United States $0.327B 37.04
Bovie Medical (APYX) United States $0.265B 0.00
United Health Products (UEEC) United States $0.262B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.250B 0.00
Viemed Healthcare (VMD) United States $0.233B 24.52
Vapotherm (VAPO) United States $0.221B 0.00
Liberty Health Sciences (LHSIF) Canada $0.188B 0.00
Repro-Med Systems (KRMD) United States $0.186B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.176B 0.00
InfuSystems Holdings (INFU) United States $0.158B 798.00
Chimerix (CMRX) United States $0.145B 0.00
Female Health (VERU) United States $0.145B 0.00
Rockwell Medical (RMTI) United States $0.138B 0.00
Fonar (FONR) United States $0.129B 9.11
Cytosorbents (CTSO) United States $0.117B 0.00
MTech Acquisition (KERN) United States $0.116B 0.00
United-Guardian (UG) United States $0.091B 23.02
Oramed Pharmaceuticals (ORMP) United States $0.081B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
Nephros (NEPH) United States $0.065B 0.00
MRI Interventions (MRIC) United States $0.059B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00